Gamida Cell to Present at the RBC Capital Markets Global Healthcare Conference
Gamida Cell Ltd. (Nasdaq: GMDA) announced that CEO Julian Adams will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on May 19, 2021, at 3:40 p.m. ET. The event will be available via live webcast on the company’s website and accessible for at least 14 days afterwards. Gamida Cell focuses on advanced cell therapies for blood cancers and serious blood diseases, utilizing its cell expansion platform to develop innovative treatment options.
- None.
- None.
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph. D., chief executive officer of Gamida Cell, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 3:40 p.m. ET.
A live webcast of the presentation will be available on the “Investors & Media” section of Gamida Cell’s website at www.gamida-cell.com, and will be available for at least 14 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn or Twitter at @GamidaCellTx.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005198/en/
FAQ
When will Gamida Cell participate in the RBC Capital Markets Global Healthcare Conference?
Where can I watch the Gamida Cell presentation at the conference?
What is the focus of Gamida Cell's therapies?
How long will the webcast from Gamida Cell's conference presentation be available?
What is the stock symbol for Gamida Cell?
